US Broker Ratings

Corcept Therapeutics (CORT) Stock Analysis: Exploring a Potential 86.50% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) has captured the attention of investors with its promising growth trajectory within the biotechnology sector. Headquartered in Redwood City, California, Corcept specializes in the discovery..

Glaukos Corporation (GKOS) Stock Analysis: Navigating a 60% Potential Upside in the Medical Devices Sector

In the rapidly evolving medical devices sector, Glaukos Corporation (NYSE: GKOS) stands out as a formidable player specializing in ophthalmic pharmaceuticals and medical technologies. With a market capitalization of $4.28..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 19% Potential Upside in the Medical Devices Sector

Investors looking for opportunities in the healthcare sector may want to keep an eye on Bruker Corporation (NASDAQ: BRKR). With a market capitalization of $5.92 billion, this Massachusetts-based medical device..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Strong Buy Ratings Signal Robust Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant investor attention in the biotechnology sector, primarily due to its innovative focus on rare neuroendocrine diseases. With a market capitalization of $7.34..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Exploring an 8.35% Dividend Yield Amidst Challenging Metrics

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a formidable player in the healthcare and pharmaceutical retail sector, with a sprawling global presence that spans the United States, Europe, and..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Tenet Healthcare Corporation (NYSE: THC), a major player in the United States healthcare sector, is capturing investor attention with its robust market performance and promising growth potential. Operating across two..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unveiling a 37.59% Potential Upside in CNS Therapy Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company rooted in the healthcare sector, is making waves in the biotechnology industry with its innovative therapies targeting central nervous system (CNS) disorders...

Integer Holdings Corporation (ITGR) Stock Report: Navigating a 17.95% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) is a key player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.55 billion, the company is a..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 15.94% Potential Upside Amidst Dividend Strength and Challenges

Viatris Inc. (NASDAQ: VTRS) presents an intriguing opportunity for investors with its potential upside of 15.94%, a robust dividend yield of 4.64%, and a portfolio that spans a broad spectrum..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 14% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) continues to draw attention in the competitive biotechnology sector for its innovative genetic medicines targeting diseases with significant unmet medical needs. With a current market..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 4.24% Potential Upside and Robust Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the attention of investors with its expansive portfolio and substantial market presence. With a market capitalization..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 27% Potential Upside

For investors eyeing the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents an intriguing opportunity. With a market capitalization of $44.45 billion, this Tokyo-based pharmaceutical powerhouse is a cornerstone..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 79.51% Potential Upside in the Biotechnology Sector

In the dynamic landscape of the biotechnology sector, ADMA Biologics Inc (NASDAQ: ADMA) emerges as a compelling player with a substantial market capitalization of $3.62 billion. Headquartered in Ramsey, New..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Unraveling a 40% Upside Potential in the Biotech Arena

Avidity Biosciences, Inc. (NASDAQ: RNA) is at the forefront of innovation in the biotechnology sector, leveraging its distinctive RNA therapeutic platform to address diseases previously deemed untreatable. Headquartered in San..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unveiling Growth Potential Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the healthcare sector, operating within the biotechnology industry. With a market capitalisation of $2.39 billion, this U.S.-based biopharmaceutical company..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 35.8% Upside Potential Amidst Robust Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the Biotechnology industry, continues to capture investor interest with its innovative pharmaceutical products and promising development pipeline. Based in Dublin, Ireland,..

UnitedHealth Group (UNH) Stock Analysis: Navigating Healthcare Growth with a 1.67% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to capture investor attention with its robust market presence and strategic growth initiatives. As of the latest..

Haleon plc (HLN) Stock Analysis: Unpacking a 25.84% Potential Upside for Investors

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, has caught the eye of investors with its robust lineup of consumer healthcare products and a promising potential upside..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing Growth Potential Amid a Competitive Healthcare Landscape

RadNet, Inc. (NASDAQ: RDNT) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With its headquarters in Los Angeles, California, RadNet has carved..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 16.35% Potential Upside with a Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) remains a formidable player in the healthcare sector, known for its robust portfolio of biopharmaceutical products and pioneering vaccine development. With a market capitalization of $140.77..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds